Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 21, 2022 - Issue 1
Submit an article Journal homepage
469
Views
11
CrossRef citations to date
0
Altmetric
Drug safety evaluation

Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma

Alessia Villania Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico Ii, Naples, ItalyCorrespondence[email protected]
View further author information
,
Sonia Sofia Ocampo-Garzab Dermatology Department, Universidad Autónoma de Nuevo León, University Hospital ¨Dr. José Eleuterio González¨, Monterrey, MexicoView further author information
,
Luca Potestioa Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico Ii, Naples, ItalyView further author information
,
Gabriella Fabbrocinia Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico Ii, Naples, ItalyView further author information
,
Jorge Ocampo-Candianib Dermatology Department, Universidad Autónoma de Nuevo León, University Hospital ¨Dr. José Eleuterio González¨, Monterrey, MexicoView further author information
,
Jorge Ocampo-Garzab Dermatology Department, Universidad Autónoma de Nuevo León, University Hospital ¨Dr. José Eleuterio González¨, Monterrey, MexicoView further author information
&
Massimiliano Scalvenzia Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico Ii, Naples, ItalyView further author information
 show all
Pages 21-29 | Received 26 Jul 2021, Accepted 12 Oct 2021, Published online: 01 Nov 2021

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Luca Potestio, Matteo Megna, Alessia Villani, Sara Cacciapuoti, Massimiliano Scalvenzi & Fabrizio Martora. (2023) Herpes Zoster and COVID-19 Vaccination: A Narrative Review. Clinical, Cosmetic and Investigational Dermatology 16, pages 3323-3331.
Read now
John T. Lear, Linda M. Morris, Dylan B. Ness & Lionel D. Lewis. (2023) Pharmacokinetics and pharmacodynamics of Hedgehog pathway inhibitors used in the treatment of advanced or treatment-refractory basal cell carcinoma. Expert Review of Clinical Pharmacology 16:12, pages 1211-1220.
Read now
Alessia Villani, Massimiliano Scalvenzi, Giuseppe Micali, Fabrizio Martora, Francesco Cillo, Flavia Raia & Luca Potestio. (2023) An update on the current and emerging pharmacotherapies for basal cell carcinomas. Expert Opinion on Pharmacotherapy 0:0, pages 1-9.
Read now
Alessia Villani, Massimiliano Scalvenzi, Giuseppe Micali, Francesco Lacarrubba, Lucia Genco, Angelo Ruggiero, Luigi Fornaro, Gianluca Guerrasio & Luca Potestio. (2023) Efficacy and safety of sonidegib for the management of basal cell carcinoma: a drug safety evaluation. Expert Opinion on Drug Safety 22:7, pages 525-531.
Read now

Articles from other publishers (7)

Melania Parisi, Mariavittoria Verrillo, Maria Antonietta Luciano, Giuseppina Caiazzo, Maria Quaranta, Francesco Scognamiglio, Vincenzo Di Meo, Alessia Villani, Mariateresa Cantelli, Lucia Gallo, Giovanna G. Altobelli, Serena Poggi, Riccardo Spaccini & Gabriella Fabbrocini. (2023) Use of Natural Agents and Agrifood Wastes for the Treatment of Skin Photoaging. Plants 12:4, pages 840.
Crossref
Vahide Saeidi, Nicole Doudican & John A. Carucci. (2023) Understanding the squamous cell carcinoma immune microenvironment. Frontiers in Immunology 14.
Crossref
Adam Khorasanchi, Richard Wu, Kari Kendra & Claire Verschraegen. (2022) Recent Advances in Immunotherapy for Patients with Head and Neck Cutaneous Squamous Cell Carcinoma. Cancers 14:21, pages 5325.
Crossref
Jonas K. Kurzhals, Gina Klee, Victoria Hagelstein, Detlef Zillikens, Patrick Terheyden & Ewan A. Langan. (2022) Disease Recurrence during Adjuvant Immune Checkpoint Inhibitor Treatment in Metastatic Melanoma: Clinical, Laboratory, and Radiological Characteristics in Patients from a Single Tertiary Referral Center. International Journal of Molecular Sciences 23:18, pages 10723.
Crossref
Yavar Shiravand, Faezeh Khodadadi, Seyyed Mohammad Amin Kashani, Seyed Reza Hosseini-Fard, Shadi Hosseini, Habib Sadeghirad, Rahul Ladwa, Ken O’Byrne & Arutha Kulasinghe. (2022) Immune Checkpoint Inhibitors in Cancer Therapy. Current Oncology 29:5, pages 3044-3060.
Crossref
Alessia Villani, Luca Potestio, Gabriella Fabbrocini & Massimiliano Scalvenzi. (2022) New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma. Advances in Therapy 39:3, pages 1164-1178.
Crossref
Davide Fattore, Luca Potestio, Lucia Genco, Cecile Pages, Ariadna Ortiz, Gabriella Fabbrocini & Vincent Sibaud. (2022) Autoimmune Skin Diseases and Immune Checkpoint Inhibitors. Critical Reviews in Immunology 42:3, pages 11-22.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.